List of works - Jonas Bergh

A Phase I study of CHS 828 in patients with solid tumor malignancy

scientific article

A catalyst for change: the European cancer Patient's Bill of Rights

scientific article published on 03 February 2014

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationships exemplified by paclitaxel myelosuppression*

scientific article published on 01 January 1998

A retrospective study of SBRT of metastases in patients with primary sarcoma

scientific article

A simple method for assigning genomic grade to individual breast tumours

scientific article

Adjuvant chemotherapy for breast cancer--"one fits all"?

scientific article

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

scientific article

Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide ⬇️

scientific article published on December 12, 1997

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

scientific article

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

scholarly article

An iron regulatory gene signature predicts outcome in breast cancer.

scientific article published on 29 August 2011

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms ⬇️

scientific article published on June 22, 2012

Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity ⬇️

scientific article published on 01 January 2002

Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy-cytotoxicity, duration and responsiveness

scientific article published on December 2003

Breast cancer associated with primary hyperparathyroidism: a nested case control study

scientific article

Breast cancer biology and the future of tailored therapies ⬇️

scientific article published on August 1, 2013

Breast tumour stroma is a prognostic indicator and target for therapy

scientific article

Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities

scientific article published on 01 September 1997

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

scientific article

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection ofp53 gene mutations using cDNA sequencing in human breast tumors ⬇️

scientific article published on August 21, 1998

Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes

scientific article

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications

scientific article published on 8 September 2015

Correlation test to assess low-level processing of high-density oligonucleotide microarray data

scientific article

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

scientific article

Differential synthesis and binding of hyaluronan by human breast cancer cell lines ⬇️

scientific article published on 01 November 1996

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

scientific article

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

scientific article (publication date: 2016)

Enhanced Expression of Neuropeptides in Human Breast Cancer Cell Lines Following Irradiation ⬇️

scientific article published on January 1, 1998

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

scientific article published on January 2007

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

scientific article

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

scientific article

Great risk of future problems for Swedish cancer care

scientific article published on 01 October 2010

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

scientific article published on July 2008

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

scientific article published on 14 September 2016

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

scientific article

Homozygous deletions at 3p12 in breast and lung cancer ⬇️

scientific article (publication date: October 1998)

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

scientific article published on 30 June 2006

How to treat male breast cancer

scientific article published on December 2007

Hurdles in anticancer drug development from a regulatory perspective ⬇️

scientific article published on February 21, 2012

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen ⬇️

scientific article published on October 19, 2010

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

scientific article

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort ⬇️

scientific article published on November 15, 2001

Increased radioresistance of an in vitro transformed human small cell lung cancer cell line ⬇️

scientific article published on June 1, 1995

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

scientific article published on January 2007

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer ⬇️

scientific article published on May 29, 2011

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

scientific article published on 29 April 2013

Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. Ablation

scientific article published on 11 December 2020

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

scientific article published on January 2006

Long-term outcome in young women with breast cancer: a population-based study

scientific article published on 13 September 2016

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method

scientific article

Multidisciplinary meeting on male breast cancer: summary and research recommendations

scientific article

Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide ⬇️

scientific article published on 01 September 1998

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study ⬇️

scientific article published on December 13, 2010

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients ⬇️

scientific article published on May 1, 2003

Production of a motility factor by a newly established lung adenocarcinoma cell line

scientific article published on March 1, 1998

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers ⬇️

scientific article published on 01 February 1998

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

scientific article published on 04 June 2009

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

scientific article

Radiotherapy of breast cancer after breast-conserving surgery: an improved technique using mixed electron–photon beams with a multileaf collimator ⬇️

scientific article published on 01 January 1998

Reducing the global breast cancer burden: the importance of patterns of care research

scientific article

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo

scientific article

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers

scientific article

Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CT ⬇️

scientific article published on 01 February 1998

Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities

scientific article published on March 1, 1998

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

scientific article published in June 2007

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

scientific article

The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for hu

scientific article

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal product

scientific article

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

scientific article

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial ⬇️

scientific article published on August 1, 1997

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer

scientific article

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study

scientific article

Transcriptional consequences of genomic structural aberrations in breast cancer

scientific article

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

scientific article

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

scientific article

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

scientific article

Validation of a radiosensitivity molecular signature in breast cancer.

scientific article published on 25 July 2012

Validation of a yeast functional assay for p53 mutations using clonal sequencing ⬇️

scientific article published on December 1, 2013

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial

scientific article

Who Should Not Receive Adjuvant Chemotherapy? International Databases ⬇️

scientific article published on January 1, 2001

p53 Status predicts survival in breast cancer patients treated with or without postoperative radiotherapy: a novel hypothesis based on clinical findings ⬇️

scientific article published on November 1, 1995

List of works by Jonas Bergh

A Phase I study of CHS 828 in patients with solid tumor malignancy

A catalyst for change: the European cancer Patient's Bill of Rights

A general model for time-dissociated pharmacokinetic-pharmacodynamic relationships exemplified by paclitaxel myelosuppression*

A retrospective study of SBRT of metastases in patients with primary sarcoma

A simple method for assigning genomic grade to individual breast tumours

Adjuvant chemotherapy for breast cancer--"one fits all"?

Age-specific trends of survival in metastatic breast cancer: 26 years longitudinal data from a population-based cancer registry in Stockholm, Sweden

Alkaline single-cell gel electrophoresis and human biomonitoring for genotoxicity: a pilot study on breast cancer patients undergoing chemotherapy including cyclophosphamide ⬇️

An expression signature for p53 status in human breast cancer predicts mutation status, transcriptional effects, and patient survival

An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

An iron regulatory gene signature predicts outcome in breast cancer.

Analysis of Cyclin D1 in Breast Cancer: A Call to Arms ⬇️

Angiogenesis in invasive breast carcinoma—a prospective study of tumour heterogeneity ⬇️

Best use of adjuvant systemic therapies II, chemotherapy aspects: dose of chemotherapy-cytotoxicity, duration and responsiveness

Breast cancer associated with primary hyperparathyroidism: a nested case control study

Breast cancer biology and the future of tailored therapies ⬇️

Breast tumour stroma is a prognostic indicator and target for therapy

Characterisation of the G1/S cell cycle checkpoint defect in lung carcinoma cells with different intrinsic radiosensitivities

Clinical instability of breast cancer markers is reflected in long-term in vitro estrogen deprivation studies

Comparison between p53 protein measurements using the luminometric immunoassay and immunohistochemistry with detection ofp53 gene mutations using cDNA sequencing in human breast tumors ⬇️

Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes

Contrasting breast cancer molecular subtypes across serial tumor progression stages: biological and prognostic implications

Correlation test to assess low-level processing of high-density oligonucleotide microarray data

Definition of clinically distinct molecular subtypes in estrogen receptor-positive breast carcinomas through genomic grade

Differential synthesis and binding of hyaluronan by human breast cancer cell lines ⬇️

Dose intense, dose dense and tailored dose adjuvant chemotherapy for early breast cancer: an evolution of concepts

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

Enhanced Expression of Neuropeptides in Human Breast Cancer Cell Lines Following Irradiation ⬇️

Erythropoietin therapy and cancer related anaemia: updated Swedish recommendations

Expression of Nestin associates with BRCA1 mutations, a basal-like phenotype and aggressive breast cancer

Gene expression profiling spares early breast cancer patients from adjuvant therapy: derived and validated in two population-based cohorts

Great risk of future problems for Swedish cancer care

Growth-inhibitory and tumor- suppressive functions of p53 depend on its repression of CD44 expression

High expression of stromal PDGFRβ is associated with reduced benefit of tamoxifen in breast cancer

High-dose chemotherapy with autologous stem-cell support as adjuvant therapy in breast cancer: overview of 15 randomized trials.

Homozygous deletions at 3p12 in breast and lung cancer ⬇️

Hormone-replacement therapy influences gene expression profiles and is associated with breast-cancer prognosis: a cohort study

How to treat male breast cancer

Hurdles in anticancer drug development from a regulatory perspective ⬇️

Immunohistochemistry compared to cytosol assays for determination of estrogen receptor and prediction of the long-term effect of adjuvant tamoxifen ⬇️

Inactivation of FBXW7/hCDC4-β expression by promoter hypermethylation is associated with favorable prognosis in primary breast cancer

Increased p53 mutation frequency during tumor progression--results from a breast cancer cohort ⬇️

Increased radioresistance of an in vitro transformed human small cell lung cancer cell line ⬇️

Inhibitory effects of estrogen receptor beta on specific hormone-responsive gene expression and association with disease outcome in primary breast cancer

Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer ⬇️

Interactions between immunity, proliferation and molecular subtype in breast cancer prognosis

Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. Ablation

Intrinsic molecular signature of breast cancer in a population-based cohort of 412 patients

Long-term outcome in young women with breast cancer: a population-based study

MICADo - Looking for Mutations in Targeted PacBio Cancer Data: An Alignment-Free Method

Multidisciplinary meeting on male breast cancer: summary and research recommendations

Multimodality treatment of 128 patients with locally advanced breast carcinoma in the era of mammography screening using standard polychemotherapy with 5-fluorouracil, epirubicin, and cyclophosphamide ⬇️

Phase III Randomized Study Comparing Docetaxel Plus Trastuzumab With Vinorelbine Plus Trastuzumab As First-Line Therapy of Metastatic or Locally Advanced Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer: The HERNATA Study ⬇️

Population pharmacokinetic modelling of unbound and total plasma concentrations of paclitaxel in cancer patients ⬇️

Production of a motility factor by a newly established lung adenocarcinoma cell line

Prognostic and predictive value of c-erbB-2 overexpression in primary breast cancer, alone and in combination with other prognostic markers ⬇️

Prognostic significance of stromal platelet-derived growth factor beta-receptor expression in human breast cancer

Proteomics profiling identify CAPS as a potential predictive marker of tamoxifen resistance in estrogen receptor positive breast cancer

Radiotherapy of breast cancer after breast-conserving surgery: an improved technique using mixed electron–photon beams with a multileaf collimator ⬇️

Reducing the global breast cancer burden: the importance of patterns of care research

Sequencing of breast cancer stem cell populations indicates a dynamic conversion between differentiation states in vivo

Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers

Skeletal metastases from breast cancer: uptake of 18 F-fluoride measured with positron emission tomography in correlation with CT ⬇️

Spontaneous and radiation-induced apoptosis in lung carcinoma cells with different intrinsic radiosensitivities

Strong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation series

TP53 status for prediction of sensitivity to taxane versus non-taxane neoadjuvant chemotherapy in breast cancer (EORTC 10994/BIG 1-00): a randomised phase 3 trial

The European Medicines Agency Review of Pertuzumab for the treatment of adult patients with HER2-positive metastatic or locally recurrent unresectable breast cancer: summary of the scientific assessment of the committee for medicinal products for hu

The European Medicines Agency approval of axitinib (Inlyta) for the treatment of advanced renal cell carcinoma after failure of prior treatment with sunitinib or a cytokine: summary of the scientific assessment of the committee for medicinal product

The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer

The cost-effectiveness of routine postoperative radiotherapy after sector resection and axillary dissection for breast cancer stage I. Results from a randomized trial ⬇️

The dyslexia candidate gene DYX1C1 is a potential marker of poor survival in breast cancer

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study

Transcriptional consequences of genomic structural aberrations in breast cancer

Vaccination with a plasmid DNA encoding HER-2/neu together with low doses of GM-CSF and IL-2 in patients with metastatic breast carcinoma: a pilot clinical trial

Validation and clinical utility of a 70-gene prognostic signature for women with node-negative breast cancer

Validation of a novel procedure for quantification of the formation of phosphoramide mustard by individuals treated with cyclophosphamide.

Validation of a radiosensitivity molecular signature in breast cancer.

Validation of a yeast functional assay for p53 mutations using clonal sequencing ⬇️

Validation of gene signatures that predict the response of breast cancer to neoadjuvant chemotherapy: a substudy of the EORTC 10994/BIG 00-01 clinical trial